Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

J Helman

Showing results (171-180 of 211) with videos related to

Pageof 22
Sort By:
Medical and Pediatric Oncology|February 12, 2002
Pilot trial of tumor-specific peptide vaccination and continuous infusion interleukin-2 in patients with recurrent Ewing sarcoma and alveolar rhabdomyosarcoma: an inter-institute NIH studyRamzi Dagher, Lauren M Long, Elizabeth J Read, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|January 23, 2016
Response to Early Treatment Evaluated with 18F-FDG PET and PERCIST 1.0 Predicts Survival in Patients with Ewing Sarcoma Family of Tumors Treated with a Monoclonal Antibody to the Insulinlike Growth Factor 1 ReceptorJoo Hyun O, Brandon S Luber, Jeffrey P Leal, et al.
International Journal of Oncology|December 18, 2001
Seven BMPs and all their receptors are simultaneously expressed in osteosarcoma cellsGiuliana Gobbi, Luca Sangiorgi, Luca Lenzi, et al.
Journal of Pediatric Hematology/Oncology|September 19, 2008
Hypocalcemia in a patient with osteosarcoma and 22q11.2 deletion syndromeFrancis J Mussai, Lea C Cunningham, Geoffrey Rezvani, et al.
Journal of the National Cancer Institute|June 10, 2011
Identification of an inhibitor of the EWS-FLI1 oncogenic transcription factor by high-throughput screeningPatrick J Grohar, Girma M Woldemichael, Laurie B Griffin, et al.
Molecular Cancer Therapeutics|May 7, 2020
EWS-FLI1-regulated Serine Synthesis and Exogenous Serine are Necessary for Ewing Sarcoma Cellular Proliferation and Tumor GrowthSameer H Issaq, Arnulfo Mendoza, Ria Kidner, et al.
European Journal of Human Genetics : EJHG|July 16, 2015
Carney triad can be (rarely) associated with germline succinate dehydrogenase defectsSosipatros A Boikos, Paraskevi Xekouki, Elena Fumagalli, et al.
Cancer Research|April 6, 2007
Phosphoprotein pathway mapping: Akt/mammalian target of rapamycin activation is negatively associated with childhood rhabdomyosarcoma survivalEmanuel F Petricoin, Virginia Espina, Robyn P Araujo, et al.
Cancer|December 8, 2020
SARC025 arms 1 and 2: A phase 1 study of the poly(ADP-ribose) polymerase inhibitor niraparib with temozolomide or irinotecan in patients with advanced Ewing sarcomaRashmi Chugh, Karla V Ballman, Lee J Helman, et al.
Clinical & Experimental Metastasis|December 12, 2007
Inhibition of the CXCR4/CXCL12 chemokine pathway reduces the development of murine pulmonary metastasesSu Young Kim, Chih Hung Lee, Brieanne V Midura, et al.
Pageof 22

Showing results (171-180 of 211) with videos related to

Sort By:
Pageof 22
Medical and Pediatric Oncology|February 12, 2002
Pilot trial of tumor-specific peptide vaccination and continuous infusion interleukin-2 in patients with recurrent Ewing sarcoma and alveolar rhabdomyosarcoma: an inter-institute NIH studyRamzi Dagher, Lauren M Long, Elizabeth J Read, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|January 23, 2016
Response to Early Treatment Evaluated with 18F-FDG PET and PERCIST 1.0 Predicts Survival in Patients with Ewing Sarcoma Family of Tumors Treated with a Monoclonal Antibody to the Insulinlike Growth Factor 1 ReceptorJoo Hyun O, Brandon S Luber, Jeffrey P Leal, et al.
International Journal of Oncology|December 18, 2001
Seven BMPs and all their receptors are simultaneously expressed in osteosarcoma cellsGiuliana Gobbi, Luca Sangiorgi, Luca Lenzi, et al.
Journal of Pediatric Hematology/Oncology|September 19, 2008
Hypocalcemia in a patient with osteosarcoma and 22q11.2 deletion syndromeFrancis J Mussai, Lea C Cunningham, Geoffrey Rezvani, et al.
Journal of the National Cancer Institute|June 10, 2011
Identification of an inhibitor of the EWS-FLI1 oncogenic transcription factor by high-throughput screeningPatrick J Grohar, Girma M Woldemichael, Laurie B Griffin, et al.
Molecular Cancer Therapeutics|May 7, 2020
EWS-FLI1-regulated Serine Synthesis and Exogenous Serine are Necessary for Ewing Sarcoma Cellular Proliferation and Tumor GrowthSameer H Issaq, Arnulfo Mendoza, Ria Kidner, et al.
European Journal of Human Genetics : EJHG|July 16, 2015
Carney triad can be (rarely) associated with germline succinate dehydrogenase defectsSosipatros A Boikos, Paraskevi Xekouki, Elena Fumagalli, et al.
Cancer Research|April 6, 2007
Phosphoprotein pathway mapping: Akt/mammalian target of rapamycin activation is negatively associated with childhood rhabdomyosarcoma survivalEmanuel F Petricoin, Virginia Espina, Robyn P Araujo, et al.
Cancer|December 8, 2020
SARC025 arms 1 and 2: A phase 1 study of the poly(ADP-ribose) polymerase inhibitor niraparib with temozolomide or irinotecan in patients with advanced Ewing sarcomaRashmi Chugh, Karla V Ballman, Lee J Helman, et al.
Clinical & Experimental Metastasis|December 12, 2007
Inhibition of the CXCR4/CXCL12 chemokine pathway reduces the development of murine pulmonary metastasesSu Young Kim, Chih Hung Lee, Brieanne V Midura, et al.
Pageof 22